Intravenous Thrombolysis After Reversal of Dabigatran With Idarucizumab in Acute Ischemic Stroke: A Case Report

Background: As there is a growing concern about the cerebral embolism events secondary to non-valvular atrial fibrillation (NVAF), novel oral anticoagulant (NOAC) has been more and more widely used as an anticoagulation treatment for the prevention of stroke. However, in the face of life-threatening...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Dan, Wang, Xuefan, Li, Yao, Chen, Ruiling, Zhao, Yingying, Xu, Chunling, Zhang, Qian, Zhang, Yongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713555/
https://www.ncbi.nlm.nih.gov/pubmed/34970137
http://dx.doi.org/10.3389/fnagi.2021.765037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713555/
https://www.ncbi.nlm.nih.gov/pubmed/34970137
http://dx.doi.org/10.3389/fnagi.2021.765037

Ejemplares similares